NCT02358031 2025-07-18MK-3475-048Merck Sharp & Dohme LLCPhase 3 Completed882 enrolled 50 charts 1 FDA
NCT03866967 2025-02-27A Study of Anti-PD-1 AK105 in Patients With Metastatic Nasopharyngeal CarcinomaAkesoPhase 2 Completed130 enrolled 1 FDA
NCT02034110 2023-08-21Efficacy and Safety of the Combination Therapy of Dabrafenib and Trametinib in Subjects With BRAF V600E- Mutated Rare CancersNovartisPhase 2 Completed206 enrolled 40 charts 2 FDA